TML data on bevacizumab for colorectal cancer 'validate practice in the community'April 9, 2013Gastroenterology
Lower Treatment Cost Doesn't Mean Lower Quality CareNovember 5, 2012GastroenterologyBusiness of Medicine
Cetuximab plus FOLFIRI in first-line treatment of KRAS mutation-negative, EGFR-positive metastatic colorectal cancerOctober 1, 2012Gastroenterology
Community Oncology Podcast - Aflibercept plus FOLFIRI for metastatic colorectal cancerApril 30, 2012Gastroenterology
Aflibercept plus FOLFIRI improves survival in second-line treatment of metastatic colorectal cancerApril 1, 2012Gastroenterology
Posterior reversible encephalopathy syndrome: a potential side effect of gemcitabineJanuary 1, 2012Gastroenterology
